LN-556026
(R)-10-(2,4,5-trifluorobenzyl)-3-(trifluoromethyl)-6,7,10,11-tetrahydro-[1,2,4]triazolo[3,4-c][1,4,7]triazecine-8,12(5H,9H)-dione , >95% , 2088771-61-1
CAS NO.:2088771-61-1
Empirical Formula: C16H13F6N5O2
Molecular Weight: 421.3
MDL number: MFCD32669788
Update time: 2023-04-23
PRODUCT Properties
| Melting point: | >189°C (dec.) |
| Density | 1.67±0.1 g/cm3(Predicted) |
| storage temp. | -20°C Freezer, Under inert atmosphere |
| solubility | DMSO (Slightly), Methanol (Slightly) |
| pka | 12.02±0.40(Predicted) |
| form | Solid |
| color | White to Off-White |
| InChI | InChI=1S/C16H13F6N5O2/c17-9-6-11(19)10(18)4-7(9)3-8-5-12(28)23-1-2-27-13(14(29)24-8)25-26-15(27)16(20,21)22/h4,6,8H,1-3,5H2,(H,23,28)(H,24,29)/t8-/m1/s1 |
| InChIKey | CJUCSNDPMOGZTM-MRVPVSSYSA-N |
| SMILES | N1[C@H](CC2=CC(F)=C(F)C=C2F)CC(=O)NCCN2C(C(F)(F)F)=NN=C2C1=O |
Description and Uses
(10R)-Sitagliptin Triazecine Analog is related to the family of Sitagliptin compounds which has recently been approved for the therapy of type II diabetes.

![(R)-10-(2,4,5-trifluorobenzyl)-3-(trifluoromethyl)-6,7,10,11-tetrahydro-[1,2,4]triazolo[3,4-c][1,4,7]triazecine-8,12(5H,9H)-dione](https://img.chemicalbook.com/CAS/20180527/GIF/2088771-61-1.gif)


![(R)-tert-Butyl(4-oxo-4-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-1-(2,4,5-trifluorophenyl)butan-2-yl)carbamate](https://img.chemicalbook.com/CAS/20200611/GIF/486460-23-5.gif)

![1-(3-(Trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)butane-1,3-dione](https://img.chemicalbook.com/CAS/GIF/764667-65-4.gif)